Ferrarini M - Search Results

1

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.

Belloni D, Heltai S, Ponzoni M, Villa A, Vergani B, Pecciarini L, Marcatti M, Girlanda S, Tonon G, Ciceri F, Caligaris-Cappio F, Ferrarini M, Ferrero E. Belloni D, et al. Among authors: ferrarini m. Haematologica. 2018 Apr;103(4):707-716. doi: 10.3324/haematol.2017.167486. Epub 2018 Jan 11. Haematologica. 2018. PMID: 29326121 Free PMC article.

2

Ex-vivo dynamic 3-D culture of human tissues in the RCCS™ bioreactor allows the study of Multiple Myeloma biology and response to therapy.

Ferrarini M, Steimberg N, Ponzoni M, Belloni D, Berenzi A, Girlanda S, Caligaris-Cappio F, Mazzoleni G, Ferrero E. Ferrarini M, et al. PLoS One. 2013 Aug 26;8(8):e71613. doi: 10.1371/journal.pone.0071613. eCollection 2013. PLoS One. 2013. PMID: 23990965 Free PMC article.

3

Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.

Belloni D, Marcatti M, Ponzoni M, Ciceri F, Veschini L, Corti A, Caligaris Cappio F, Ferrarini M, Ferrero E. Belloni D, et al. Among authors: ferrarini m. Exp Cell Res. 2015 Jan 1;330(1):1-12. doi: 10.1016/j.yexcr.2014.10.017. Epub 2014 Oct 24. Exp Cell Res. 2015. PMID: 25447443

4

Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.

Bianco M, Gasparri AM, Colombo B, Curnis F, Girlanda S, Ponzoni M, Bertilaccio MT, Calcinotto A, Sacchi A, Ferrero E, Ferrarini M, Chesi M, Bergsagel PL, Bellone M, Tonon G, Ciceri F, Marcatti M, Caligaris-Cappio F, Corti A. Bianco M, et al. Among authors: ferrarini m. Cancer Res. 2016 Apr 1;76(7):1781-91. doi: 10.1158/0008-5472.CAN-15-1637. Epub 2016 Feb 11. Cancer Res. 2016. PMID: 26869462

5

3D-Dynamic Culture Models of Multiple Myeloma.

Ferrarini M, Steimberg N, Boniotti J, Berenzi A, Belloni D, Mazzoleni G, Ferrero E. Ferrarini M, et al. Methods Mol Biol. 2017;1612:177-190. doi: 10.1007/978-1-4939-7021-6_13. Methods Mol Biol. 2017. PMID: 28634943

6

[No title available]

[No authors listed] [No authors listed] PMID: 31727767

7

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.

Botrugno OA, Bianchessi S, Zambroni D, Frenquelli M, Belloni D, Bongiovanni L, Girlanda S, Di Terlizzi S, Ferrarini M, Ferrero E, Ponzoni M, Marcatti M, Tonon G. Botrugno OA, et al. Among authors: ferrarini m. Haematologica. 2020 Oct 1;105(10):2440-2447. doi: 10.3324/haematol.2018.215210. Haematologica. 2020. PMID: 33054085 Free PMC article.

8

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Belloni D, Ferrarini M, Ferrero E, Guzzeloni V, Barbaglio F, Ghia P, Scielzo C. Belloni D, et al. Among authors: ferrarini m. STAR Protoc. 2022 Aug 10;3(3):101601. doi: 10.1016/j.xpro.2022.101601. eCollection 2022 Sep 16. STAR Protoc. 2022. PMID: 35990738 Free PMC article.

9

Proteasome inhibitors and modulators of angiogenesis in multiple myeloma.

Ferrarini M, Ferrero E. Ferrarini M, et al. Curr Med Chem. 2011;18(34):5185-95. doi: 10.2174/092986711798184316. Curr Med Chem. 2011. PMID: 22087819 Review.

10

MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.

Girlanda S, Fortis C, Belloni D, Ferrero E, Ticozzi P, Sciorati C, Tresoldi M, Vicari A, Spies T, Groh V, Caligaris-Cappio F, Ferrarini M. Girlanda S, et al. Among authors: ferrarini m. Cancer Res. 2005 Aug 15;65(16):7502-8. doi: 10.1158/0008-5472.CAN-05-0731. Cancer Res. 2005. PMID: 16103105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters